icon-folder.gif   Conference Reports for NATAP  
 
  18th European AIDS Conference
October 27th-30th, 2021
Online & United Kingdom
Back grey_arrow_rt.gif
 
 
 
Long-term efficacy of bictegravir/emtricitabine/tenofovir alafenamide after switch from boosted protease inhibitor-based regimens including in those with preexisting resistance and viral blips
 
 
  EACS 2021 Oct 27-30
 
K. Andreatta1, S. Chang1, M. Delaney1, M. Willkom1, R. Martin1, H. Graham1, H. Martin1, K.L. White1
 
1Gilead Sciences, Inc., Foster City, United States

1030211

1030212

1030213

1030214

1030215

1030216

1030217

1030218

1030219

10302110